DIAGNOS Inc. - ROE
DGNOF
Price:
$0.15
Market Cap:
$23.68M
DIAGNOS Inc. specializes in delivering technology-driven services, with its reach primarily extending across Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. A cornerstone of its offerings is Computer Assisted Retina Analysis (CARA), a web-based software application in the healthcare sector. This innovative tool is designed to aid medical professionals in identifying diabetic retinopathy, empowering eye care specialists to clearly visualize both normal anatomical features of the retina and any disease-related changes. Beyond its medical applications, the company also furnishes expert consulting services in the domains of data analytics and artificial intellig...[Read more]
Industry
Medical - Healthcare Information Services
IPO Date
2003-06-24
Stock Exchange
OTC
Ticker
DGNOF
PE Ratio
[-5.00]
ROE
[11.66%]
Current Ratio
[1.49]
Dividend Yield
[0%]
Enterprise Value
[24.77M]
Dividend History
The ROE as of June 2026 (TTM) for DIAGNOS Inc. (DGNOF) is 11.66%
According to DIAGNOS Inc.’s latest financial reports and current stock price. The company's current ROE is 11.66%. This represents a change of -117037.71% compared to the average of -9.97% of the last 4 quarters.
DIAGNOS Inc. (DGNOF) Historical ROE (quarterly & annually)
How has DGNOF ROE performed in the past?
The mean historical ROE of DIAGNOS Inc. over the last ten years is -14.11%. The current 11.66% ROE has changed -82726.94% with respect to the historical average. Over the past ten years (40 quarters), DGNOF's ROE was at its highest in in the June 2019 quarter at 28.53%. The ROE was at its lowest in in the September 2019 quarter at -1456.01%.
Average
-14.11%
Median
75.53%
Minimum
-1838.81%
Maximum
2.30%
DIAGNOS Inc. (DGNOF) ROE by Quarter and Year
Discovering the peaks and valleys of DIAGNOS Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 2.30%
Minimum Annual Increase = -1898.31%
Minimum Annual ROE = -1838.81%
| Year | ROE | Change |
|---|---|---|
| 2026 | -663.16% | -63.94% |
| 2025 | -1838.81% | -1898.31% |
| 2024 | 102.25% | -95.55% |
| 2023 | 2.30% | -1368.19% |
| 2022 | -181.19% | -2.57% |
| 2021 | -185.96% | -346.19% |
| 2020 | 75.53% | 0% |
| 2019 | 75.53% | -5.19% |
| 2018 | 79.66% | -18.06% |
| 2017 | 97.23% | -4.10% |
DIAGNOS Inc. (DGNOF) Average ROE
How has DGNOF ROE performed in the past?
The current ROE of DIAGNOS Inc. (DGNOF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-799.90%
5-year avg
-56.62%
10-year avg
-14.11%
DIAGNOS Inc. (DGNOF) ROE vs. Peers
How is DGNOF’s ROE compared to its peers?
DIAGNOS Inc.’s ROE is greater than Marpai, Inc. (49.95%), greater than Alternate Health Corp. (-279.24%), greater than ImpediMed Limited (-165.13%), greater than Cordlife Group Limited (-5.67%), greater than Starpharma Holdings Limited (-15.96%), greater than BioMark Diagnostics Inc. (-153.00%), greater than Bonus BioGroup Ltd. (-1541.00%), greater than Celyad Oncology S.A. (-242.11%), greater than Positron Corporation (-767.26%), greater than CareView Communications, Inc. (7.12%),
| Company | ROE | Market cap |
|---|---|---|
| 49.95% | $13.08M | |
| -279.24% | $7.79K | |
| -165.13% | $13.80M | |
| -5.67% | $38.57M | |
| -15.96% | $206.25M | |
| -153.00% | $41.80M | |
| -1541.00% | $151.83M | |
| -242.11% | $11.19M | |
| -767.26% | $25.98M | |
| 7.12% | $35.03M |
Build a custom stock screener for DIAGNOS Inc. (DGNOF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DIAGNOS Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
DIAGNOS Inc. (DGNOF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like DIAGNOS Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is DIAGNOS Inc.'s ROE?
How is the ROE calculated for DIAGNOS Inc. (DGNOF)?
What is the highest ROE for DIAGNOS Inc. (DGNOF)?
What is the 3-year average ROE for DIAGNOS Inc. (DGNOF)?
What is the 5-year average ROE for DIAGNOS Inc. (DGNOF)?
How does the current ROE for DIAGNOS Inc. (DGNOF) compare to its historical average?